Evidence map›Paper›PMID 35870021›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review.

Taylor Novice, Madison Novice, David Portney, Joshua Goyert, N Lynn Henry, Jacqueline S Jeruss, Monika L Burness

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Characterization of the role of Facebook groups for patients who use scalp cooling therapy: a survey study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Taylor NoviceDepartment of Dermatology, Henry Ford Hospital, Detroit, MI, USA.
Madison NoviceUniversity of Michigan Medical School, Ann Arbor, MI, USA.
David PortneyDepartment of Ophthalmology, University of Michigan, Ann Arbor, MI, USA.
Joshua GoyertUniversity of Michigan Medical School, Ann Arbor, MI, USA.
N Lynn HenryDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Jacqueline S JerussRogel Cancer Center, 1500 E Medical Center Dr SPC 5916, Ann Arbor, MI, 48109, USA.
Monika L BurnessDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. mburness@med.umich.edu.
University of Michigan–Ann Arbor · USU-M Rogel Cancer CenterHenry Ford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChemotherapy-induced alopecia (CIA) is a stigmatizing and psychologically devasting side effect of cancer treatment. Scalp cooling therapy (SCT) is the most effective method to reduce CIA, yet it is underutilized. We investigated factors that may impact scalp cooling discussion and use.

methodsWe performed a retrospective review of cancer patients from 2000 to 2019 who had documentation of SCT discussion in the electronic medical record. The University of Michigan Rogel Cancer Center registry was used to identify the total number of cancer patients eligible for SCT during 2015-2019. Chi-square tests were used for outcome and patient characteristic comparisons (p < 0.05).

resultsFrom 2000 to 2019, 194 patients had documentation of SCT discussion. Of those, 72 (43.6%) used SCT, 93 (47.9%) did not use SCT, and the remaining 29 (17.8%) had unknown SCT use. A total of 5615 cancer patients were eligible for SCT from 2015 to 2019. As compared to those who did not have documented SCT discussions, patients who had documentation of SCT discussions in that period (n = 161, 3.0%) were more likely to be female, have breast cancer, be less than 45 years old, and live in a zip code with average income > US $100,000 (all p < 0.0001). Between 2015 and 2019, 57 patients (1.02%) used SCT. On univariate analysis, patient-initiated conversation about SCT (p = 0.01) and age less than 65 (p = 0.03) were significantly associated with decision to use SCT.

conclusionThere were distinctions in the types of patients who have documented discussions about SCT. Improving patient knowledge about the availability of SCT and increasing access to this technology for all eligible cancer patients may enable more patients to achieve improved quality of life by reducing or preventing CIA.

Indexed as

Antineoplastic AgentsBreast NeoplasmsHypothermia, InducedAlopeciaAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansMaleMiddle AgedQuality of LifeRetrospective StudiesScalpAntineoplastic AgentsChemotherapy-induced alopeciaCold cap therapyHair loss preventionManual cold capsScalp cooling therapy

Identifiers

PMID35870021
OpenAlexW4286697208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.